Li Huang, Chengcheng Liao, Zhenzhen Liang, Huajian Chen
{"title":"中国中老年人肥胖代谢异质性与抑郁进展的关联:一项前瞻性研究","authors":"Li Huang, Chengcheng Liao, Zhenzhen Liang, Huajian Chen","doi":"10.1016/j.jad.2025.119875","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In previous studies, there have been few studies focusing on the association between metabolic heterogeneity of obesity and depression. The association between metabolic heterogeneity of obesity and depression progression remains unclear.</p><p><strong>Methods: </strong>This study used data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018. Metabolic heterogeneity of obesity was assessed according to four obesity and metabolic statuses, namely metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), metabolically healthy overweight/obesity (MHOO) and metabolically unhealthy overweight/obesity (MUOO). Linear mixed-effects models were used to analyze the association between metabolic heterogeneity of obesity and depression progression.</p><p><strong>Results: </strong>After 7 years of follow-up, MUNW, MHOO, and MUOO showed accelerated depression progression compared with MHNW, with additional annual increases of 0.09 (95 % CI: 0.02 to 0.17), 0.12 (95 % CI: 0.03 to 0.20), and 0.10 (95 % CI: 0.04 to 0.17). Participants with stable MUNW, MHOO, MUOO, MHNW transition to MUNW, and weight change in metabolically abnormal states exhibited accelerated depression progression compared to stable MHNW. And accelerated depression progression was significant in MUNW, MHOO, and MUOO among participants without social activities.</p><p><strong>Conclusions: </strong>Although MUNW, MHOO, and MUOO exhibited milder depressive symptoms at baseline compared to MHNW, these phenotypes were associated with an accelerated depression progression over time. Additionally, social activities can mitigate the acceleration of depression progression. Our findings highlighted the important role of obesity and metabolic status and their shifts in the depression progression in middle-aged and older adults, and emphasized the buffering role of positive social activities.</p>","PeriodicalId":14963,"journal":{"name":"Journal of affective disorders","volume":" ","pages":"119875"},"PeriodicalIF":4.9000,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Associations of metabolic heterogeneity of obesity with depression progression among middle-aged and older adults in China: A prospective study.\",\"authors\":\"Li Huang, Chengcheng Liao, Zhenzhen Liang, Huajian Chen\",\"doi\":\"10.1016/j.jad.2025.119875\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>In previous studies, there have been few studies focusing on the association between metabolic heterogeneity of obesity and depression. The association between metabolic heterogeneity of obesity and depression progression remains unclear.</p><p><strong>Methods: </strong>This study used data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018. Metabolic heterogeneity of obesity was assessed according to four obesity and metabolic statuses, namely metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), metabolically healthy overweight/obesity (MHOO) and metabolically unhealthy overweight/obesity (MUOO). Linear mixed-effects models were used to analyze the association between metabolic heterogeneity of obesity and depression progression.</p><p><strong>Results: </strong>After 7 years of follow-up, MUNW, MHOO, and MUOO showed accelerated depression progression compared with MHNW, with additional annual increases of 0.09 (95 % CI: 0.02 to 0.17), 0.12 (95 % CI: 0.03 to 0.20), and 0.10 (95 % CI: 0.04 to 0.17). Participants with stable MUNW, MHOO, MUOO, MHNW transition to MUNW, and weight change in metabolically abnormal states exhibited accelerated depression progression compared to stable MHNW. And accelerated depression progression was significant in MUNW, MHOO, and MUOO among participants without social activities.</p><p><strong>Conclusions: </strong>Although MUNW, MHOO, and MUOO exhibited milder depressive symptoms at baseline compared to MHNW, these phenotypes were associated with an accelerated depression progression over time. Additionally, social activities can mitigate the acceleration of depression progression. Our findings highlighted the important role of obesity and metabolic status and their shifts in the depression progression in middle-aged and older adults, and emphasized the buffering role of positive social activities.</p>\",\"PeriodicalId\":14963,\"journal\":{\"name\":\"Journal of affective disorders\",\"volume\":\" \",\"pages\":\"119875\"},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2025-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of affective disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.jad.2025.119875\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of affective disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jad.2025.119875","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Associations of metabolic heterogeneity of obesity with depression progression among middle-aged and older adults in China: A prospective study.
Background: In previous studies, there have been few studies focusing on the association between metabolic heterogeneity of obesity and depression. The association between metabolic heterogeneity of obesity and depression progression remains unclear.
Methods: This study used data from the China Health and Retirement Longitudinal Study (CHARLS) from 2011 to 2018. Metabolic heterogeneity of obesity was assessed according to four obesity and metabolic statuses, namely metabolically healthy normal weight (MHNW), metabolically unhealthy normal weight (MUNW), metabolically healthy overweight/obesity (MHOO) and metabolically unhealthy overweight/obesity (MUOO). Linear mixed-effects models were used to analyze the association between metabolic heterogeneity of obesity and depression progression.
Results: After 7 years of follow-up, MUNW, MHOO, and MUOO showed accelerated depression progression compared with MHNW, with additional annual increases of 0.09 (95 % CI: 0.02 to 0.17), 0.12 (95 % CI: 0.03 to 0.20), and 0.10 (95 % CI: 0.04 to 0.17). Participants with stable MUNW, MHOO, MUOO, MHNW transition to MUNW, and weight change in metabolically abnormal states exhibited accelerated depression progression compared to stable MHNW. And accelerated depression progression was significant in MUNW, MHOO, and MUOO among participants without social activities.
Conclusions: Although MUNW, MHOO, and MUOO exhibited milder depressive symptoms at baseline compared to MHNW, these phenotypes were associated with an accelerated depression progression over time. Additionally, social activities can mitigate the acceleration of depression progression. Our findings highlighted the important role of obesity and metabolic status and their shifts in the depression progression in middle-aged and older adults, and emphasized the buffering role of positive social activities.
期刊介绍:
The Journal of Affective Disorders publishes papers concerned with affective disorders in the widest sense: depression, mania, mood spectrum, emotions and personality, anxiety and stress. It is interdisciplinary and aims to bring together different approaches for a diverse readership. Top quality papers will be accepted dealing with any aspect of affective disorders, including neuroimaging, cognitive neurosciences, genetics, molecular biology, experimental and clinical neurosciences, pharmacology, neuroimmunoendocrinology, intervention and treatment trials.